Every accountant who took microeconomics in college learned about Production Theory, most likely in their first semester. It’s the idea that all businesses, whether they cultivate cannabis, manufacture widgets, or operate retail stores, face constraints from three specific forces that determine profitability:

1. Consumer demand is what drives revenue into the industry: how many patients are in the market, how often they purchase, what they’re willing to spend, and what products they choose. For a cultivator, demand shows up as wholesale orders from dispensaries. For a dispensary, it’s patient traffic, basket size, and the frequency of return visits. Either way, demand determines how much revenue is available to be earned.

2. Competition determines how that revenue gets divided. Every licensed cultivator competes for dispensary shelf space while every dispensary competes for patient dollars. Licensing constraints provide some insulation in a regulated market, but within the licensed universe, every operator is still fighting for their share of a finite pool.

3. Costs of production encompass everything it takes to operate: labor, energy, rent, nutrients, testing, compliance, packaging, inventory, and overhead. Collectively, they determine how much of your revenue you actually keep.

Here’s the advice you’ve heard from every consultant, accountant, and business advisor you’ve ever worked with: you can’t control demand, you can’t control competition, and the only thing you can actually control is your costs. Get efficient. Reduce waste. Lower your cost per gram. That’s how you maximize profit.

The problem that advice produces, which is invisible to anyone who believes it, is that cost reduction and product quality exist on the same line, moving in opposite directions. Cheaper labor means less experienced growers. Shorter cure times mean faster throughput but weaker product. Lower-grade nutrients, reduced testing frequency, cheaper packaging; every one of these decisions lowers your cost per gram and degrades what you’re selling.

Follow the standard advice long enough and you’ll find yourself confronted by a reality you never want to face – the only way to keep cutting is to make the product worse. And a worse product suppresses the very demand you were told you couldn’t influence in the first place. The single-lever strategy, pursued to its logical end, is self-defeating.

So how did this become the dominant advice in the first place?

Where the Standard Advice Comes From

The “control your costs” recommendation is the inevitable logic that flows from the specific economic model built to describe Production Theory; a model that’s been taught in business schools for decades, and one that rests on three assumptions about how markets work.

The first assumption is that your product is essentially the same as everyone else’s. Flower is flower, edibles are edibles, and if there’s no meaningful difference between what you sell and what your competitor sells, then nothing you do changes what the market will pay. Price gets set by forces outside your control, and you either accept it or you don’t sell.

The second assumption is that buyers have complete information. Every dispensary already knows what every cultivator offers, at what price, at what quality level. If that’s true, there’s no advantage to be gained from communicating your value more effectively than your competitors, because everyone already knows everything.

The third assumption is that purchasing decisions are purely mechanical: buyers evaluate the objective quality-to-price ratio and select the best option. In this world, relationships don’t matter, trust doesn’t factor into the equation, and reputation is irrelevant to the outcome.

If all three of these assumptions held true, the model would be accurate and the advice that flows from it would be correct. Cost control really would be your only lever, because you’d be selling an identical product to perfectly informed buyers making purely rational calculations with no room for differentiation. But look at those assumptions again and ask yourself honestly whether they describe any market you’ve ever operated in, cannabis or otherwise.

All models are wrong. Some are helpful.” – George Box, statistician (1976)

 

What the Assumptions Miss

Your product is not interchangeable with your competitor’s. Strains differ, consistency differs, testing profiles differ, packaging and presentation differ, and most importantly, the relationship between the seller and the buyer differs in ways that matter enormously. Two cultivators can offer the same strain at the same price point, and one gets the order while the other doesn’t. That outcome is invisible to the standard model, but it’s one of the most consequential things happening in your business on any given day.

Buyers don’t have complete information, either, and this is true even though most dispensaries are sitting on a POS system full of transaction data. A POS system is a record of completed transactions: what sold, at what price, in what quantity. What it doesn’t tell you is why a patient chose one product over another, whether they’ll come back for the same thing next month, whether last month’s strong seller was driven by a budtender recommendation or a temporary price drop, or what the patients who walked out without purchasing were actually looking for.

Having data is not the same as having the information you need to make confident forward-looking purchasing decisions – they are fundamentally different, and most dispensary operators are making consequential inventory bets in the gap between the two. That gap is where real uncertainty lives, and whoever helps close it with market intelligence, patient behavior insight, or product performance context the POS system can’t generate on its own holds an advantage the standard model says shouldn’t exist.

Purchasing decisions aren’t mechanical. Dispensary buyers purchase from operators they trust, reorder from cultivators who deliver consistently, not just consistent product but a consistent experience, and prioritize suppliers who make their jobs easier, who help them understand their own market, and who show up as partners rather than vendors with a price sheet. The decision to buy is shaped by trust, reliability, and the perceived value of the entire relationship, and none of those variables appear anywhere in the standard model.

When the assumptions don’t hold, neither does the conclusion. And the conclusion that cost control is your only lever is constraining your business in ways that deserve serious examination.

What Becomes Possible

If your product isn’t interchangeable, then you can influence what the market will pay for it. Not through branding gimmicks or packaging redesigns, but through the quality and consistency of what you deliver, the intelligence you provide alongside it, and the trust you build with the people who buy from you.

If buyers don’t have complete information, then the operator who provides better information holds a meaningful advantage that has nothing to do with price. The relationship between buyer and seller changes when one side helps the other make more confident decisions, and that change moves the basis of competition from cost to value in ways the standard model can’t account for.

If purchasing decisions are driven by trust rather than spreadsheets, then trust is a productive asset with direct financial consequences. It determines whether your offer gets chosen over someone else’s, whether you hold your price or get pushed into discounting, and whether your volume grows or stagnates quarter over quarter. That’s not a soft skill bolted onto the side of your business; it’s the mechanism that governs revenue.

This means you don’t have only one lever — you have all three.

You should still manage costs, and manage them well. Cost discipline is real, and the operator who doesn’t understand their true cost structure is flying blind. But cost management is the floor of profitability, not the ceiling. When cost reduction is your only strategy, you’re in a race to the bottom against every other operator in the state who got the same advice from their accountant. That race ends exactly where we described earlier, with pressure on the very quality that keeps your product moving.

The cultivator who understands how to influence demand, by helping dispensaries sell more effectively, by providing intelligence that makes purchasing decisions easier and more confident, by building relationships where reorders happen on trust rather than negotiation, operates on a different trajectory entirely. Revenue grows not because the overall market expanded but because a larger share of the market chooses to flow through them.

The dispensary operator who reshapes their competitive position, not by matching competitors on price but by building a level of patient experience and expertise that others can’t replicate, stops hemorrhaging patients to whoever is running the deepest discount this week. The patient conversation shifts from “who has the cheapest product” to “where do I get the best guidance on what actually works for my condition,” and that shift changes everything about the economics of the business.

The Vertically Integrated Illusion

This analysis matters particularly for operators who’ve invested in vertical integration, owning cultivation, processing, and retail under one roof.

Vertical integration is frequently pursued as though it solves the profitability problem outright. Own the whole chain, capture the margin at every stage, eliminate the middleman. The strategic logic feels airtight until you examine what it actually accomplishes relative to the three forces.

Vertical integration doesn’t change demand. Patients don’t visit your dispensary more often or spend more because you grew the flower in-house. It doesn’t eliminate competition, because other dispensaries and cultivators are still pursuing the same patient dollars regardless of your corporate structure. What vertical integration actually does is reorganize your cost structure by replacing an external transaction with an internal one. That can be more efficient, but it’s fundamentally a cost-side move: a more elaborate and capital-intensive version of the same single-lever strategy everyone else is running.

And the structure creates a dangerous blind spot. The vertically integrated operator often stops asking the hard questions that standalone operators can’t avoid. Why invest in building trust with dispensary purchasing managers when you are the dispensary? Why develop patient intelligence capabilities when you already have a captive retail channel? Why push your cultivation team to differentiate when your own stores will carry whatever they grow?

That kind of thinking feels like strategic confidence, but it functions as complacency. Your dispensaries still need to earn patient loyalty against every other dispensary in the zone. Your cultivation operation still needs to produce what patients actually want, because a dispensary — even one you own — cannot sell what patients don’t want to buy. And your cost structure is now considerably more complex, with internal transfer pricing across multiple divisions that may or may not reflect economic reality.

Most vertically integrated operators cannot tell you with confidence whether their cultivation arm is genuinely efficient or whether it’s being quietly subsidized by retail margins. The organizational structure that was supposed to provide clarity has made the question harder to see, not easier.

The Real Question

Who is helping you operate on all three forces — not just costs, but demand and competitive position — and building the financial architecture that lets you see clearly where your money is made and where it disappears?

Because you have three forces that determine your profitability, but you’ve only ever been told to pull the cost lever — that it’s the only one you can pull. The problem is that each pull yields less than the last, and pursued far enough, cost reduction guarantees that the quality your revenue depends on will eventually degrade.

But when cost reduction is your only strategy, the consequences don’t stay hidden. They show up as smaller ticket dollars, fewer purchases per ticket, fewer tickets altogether: revenue declining in ways that everyone around you attributes to market conditions:

“The market got harder.”

“Patients aren’t spending.”

“Competition is driving prices down.”

That’s the story you’ll hear from your advisors, and it will sound reasonable – and it will be wrong.

What they’re describing as a market problem is the predictable result of a single-lever strategy that degraded the product, the relationships, and the trust that revenue depends on. The cost of operating on one force instead of three is on every financial statement you’ve ever reviewed.

You just haven’t had a CPA with the economic training and CFO-level experience to help you see it. The operators who control forty percent of Mississippi’s cannabis revenue already do.